Anti Epileptic Drug News and Research

RSS

Australian researchers stelp closer to discovering the cause of epileptic seizures

Scientists still do not know what causes epileptic seizures, but researchers from Melbourne's Howard Florey Institute are one step closer to solving this puzzle with the help of their newly developed genetically modified epileptic mouse.

22 Oct 2007

Childhood epilepsy research offers new hope for seizure control

18 Oct 2007

Barr Labs and Par Pharmaceutical settle Diazepam patent case with Valeant

Barr Pharmaceuticals, Inc. today announced that its Barr Laboratories, Inc. subsidiary and Par Pharmaceutical Companies, Inc. have entered into a settlement agreement regarding their joint patent challenge with Valeant Pharmaceuticals North America related to Valeant's DIASTAT(R) diazepam rectal gel products.

15 Oct 2007

Caffeine and acetaminophen don't mix well

Consuming large amounts of caffeine while taking acetaminophen, one of the most widely used painkillers in the United States, could potentially cause liver damage, according to a preliminary laboratory study reported in the Oct. 15 print issue of ACS' Chemical Research in Toxicology, a monthly journal.

27 Sep 2007

Paracetamol and coffee after a big night not such a good idea

That paracetamol along with the morning coffee after a big night may not be such a good idea after all.

27 Sep 2007

Study of new epilepsy treatment underway at URMC

The University of Rochester Medical Center (URMC) is participating in a multi-center study of a new medical device to treat epilepsy. The Rochester study is being overseen by neurologists Michel Berg, M.D. and James Fessler, M.D., and neurosurgeons Web Pilcher, M.D., Ph.D. and Jason Schwalb, M.D.

15 Sep 2007

Child's IQ could be affected by mother's epilepsy

A history of maternal epilepsy and its associated treatment may be linked to impaired intelligence later in life, says a new study published in Epilepsia.

12 Sep 2007

Ovation Pharmaceuticals advances development pipeline with new phase III epilepsy study

OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood.

5 Sep 2007

Brain chip could predict and stop epilepsy seizures

An implanted stimulator being studied at Thomas Jefferson University Hospital may be able to predict and prevent seizures before they start in people with uncontrolled epilepsy.

26 Jul 2007

Call for greater research into paediatric drugs for epilepsy

Researchers have called for urgent studies into the long-term safety of newer antiepileptic drugs after discovering that the number given to children has increased significantly over recent years, reports the June issue of British Journal of Clinical Pharmacology.

14 Jun 2007

Experts call for greater research into paediatric drugs for epilepsy

8 Jun 2007

Advances in epilepsy treatment

Epilepsy and seizures affect 2.5 million Americans, 181,000 new cases of epilepsy are diagnosed every year, and the disorder incurs an estimated $12.5 billion in annual direct and indirect costs.

1 Jun 2007

Popular epilepsy drug damages the unborn

A study by researchers in the United States has found that women who took an epilepsy drug during their pregnancy had a higher risk of giving birth to children with a lower IQ or with mental retardation.

7 May 2007

Estrogen fluctuation affects epileptic seizures

In more than a third of women with epilepsy, seizures fluctuate across the menstrual cycle, due in part to continually fluctuating effects of estrogen on the neural circuitry in the hippocampus, a region of the brain involved in learning and memory - and in epileptic seizures.

1 May 2007

Epilepsy drug retigabine safe and effective

A drug for epilepsy with a new mechanism of action is safe and effective, according to a study published in the April 10, 2007, issue of Neurology", the scientific journal of the American Academy of Neurology.

10 Apr 2007

Licensing arrangement reached for antiepileptic drug developed at Hebrew University

A worldwide licensing arrangement for development, production and marketing of an antiepileptic drug created at the Hebrew University of Jerusalem has been signed by Shire Pharmaceuticals with Yissum, the Hebrew University's technology transfer company.

5 Sep 2006